IFNA2 and COVID-19: In a first study of critically ill COVID-19 patients, IFN-α2, but neither IFNβ nor IFNλ, was detected in the plasma of 21 out of 26 patients with a peak 10 days after onset of symptoms (Trouillet-Assant et al., 2020).